Finally, BBR could prevent lung cancer by modulating the peptidylarginine deiminase 4 (PADI4)-related macrophage inflammatory responses by up-regulating CD86 and decreasing CD163 and CD206 in the PADI4 overexpressed macrophages (68). The gene discussed is PADI4; the disease is lung carcinoma.